Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Immix Biopharma, Inc. | StockGist | StockGist

Companies
IMMX
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings IMMXSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Immix Biopharma, Inc.

Filed Feb 17, 2026

Accepted Feb 16, 2026, 7:00 PM ET

CIK 0001873835

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Immix Biopharma, Inc.

Person Type

IA

CUSIP: 45258H106

Recent Filings

Immix Biopharma, Inc.5 days ago

Immix Biopharma, Inc.1 weeks ago

Immix Biopharma, Inc.1 weeks ago

Immix Biopharma, Inc.1 weeks ago

Immix Biopharma, Inc.2 weeks ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice